Joined May 2023
- Tweets 2,155
- Following 529
- Followers 289
- Likes 1,178
117 Photos and videos
Pinned Tweet
Jun 10
We trained @senebiclabs on purely healthy human lung cells.Never on a single disease.Then we ran a benchmark to test it with 15 diseases it has never seen. It flagged all 15 as abnormal and recovered the correct biology in 8 of them. You don't teach a model disease,you teach it health and the disease reveals itself.
senebiclabs.com
Jun 5
Introducing @senebiclabs . We are building a system that understands what a healthy human body looks like at the cellular level,starting with the lung. So anything that departs from it can be seen, understood and eventually corrected.
Connecting Patients, Intelligence and Experts for Better Health Care.
Senebiclabs.com
1
1
89
Jun 12
This 2 guys has a combined net worth of Up to $1.18 Trillion...They are really changing the world and serving humanity
1
19
Jun 12
Your mates are out here becoming trilionnares man😂
12
Jun 12
He is actually the only big guy I can trust with AGI
Jun 12
So if you and I time travel to 2050, what does it look like?
Demis Hassabis: Wow, 2050. I mean, that's...
31
Jun 12
Elon Musk becomes the first trilionnare after SpaceX IPO...there are levels to this game
47
Jun 12
What a time to be alive:
Elon musk is the first trilionnare
Jeff Bezoz is again a founder
Godwin Yampoi is the founder of @senebiclabs
Jun 11
JUST IN: SpaceX IPO has reportedly drawn $70,000,000,000.00 in orders from retail investors.
1
1
28
godwin. _10 retweeted
The only person I’d trust with AGI.
90
31
667
29,659
Jun 11
Anyway am building @senebiclabs with a mission to solve all diseases
Jun 11
Every day I level up aiming to be the most cracked engineer then I come to X and understand that there are levels to this game😂
1
1
22
Jun 11
Every day I level up aiming to be the most cracked engineer then I come to X and understand that there are levels to this game😂
43
Jun 11
Hi all. Am Godwin,working at the intersection of medical research and ML. Am building a disease-blind model of health: a single-cell reference of a healthy lung that flags how a sample deviates from healthy, rather than detecting specific diseases.The bet is that if you model health well enough, diseases(even us unseen) shows up as deviation.Heavy user of scvi-tools and scArches. Right now I'm deep in the cross-cohort side of it, keeping a deviation signal robust to batch without integrating it away(The over integration problem). Would love to connect with anyone working on batch-robust representation, reference mapping or anomaly detection in single-cell. Glad to be here and learning from this community.
@senebiclabs
senebiclabs.com
48
Jun 11
AI just keep getting better in biology and We love it
you have no idea how much better it is getting
just this week:
- a child was successfully implanted after embryo screening for IQ in the 99.99th percentile. the default human is already being upgraded
- the first ever reverse-aging drug was injected into a human. Life Biosciences by @davidasinclair , so it begins
- Sinclair also announced plans to test an oral reprogramming pill in the $101M XPRIZE. whole-body rejuvenation. a pill you swallow
- Retro Biosciences raised new funding at a $1.8B valuation
- @newlimit announced its first medicines headed to the clinic. Brian Armstrong's $3.1B longevity bet is moving from lab to human
- Junevity published PNAS research validating transcription factor modulation can reverse cellular aging. first-in-human trials starting H2 2026
- retatrutide phase 3 confirmed 70 pounds lost on average. no plateau. bariatric surgery territory from a weekly injection
this is just week one of June 2026
bio/acc
13
godwin. _10 retweeted
17 Nov 2024
Friends and colleagues often ask, “What are the top 100 important "AI in Biology" papers that provide broad insights into the field?” 📚🔬 While narrowing it down to exactly 100 is no small feat, I’ve curated a list of foundational and impactful #BioAI papers. I'm sure the list would exceed more than 100 given the relentless expansion of this thrilling field! Please follow this thread for key insights, and please feel free to suggest any papers I may have missed!
With my background and interests, I prioritize papers in #AgingBiology, #CellBiology, and #Neuroscience. I’ll keep this thread pinned to my profile and update it regularly. I encourage everyone to add more papers from their own expertise—let’s make this interactive and foster engaging discussions! Here is a collection of essential #AIbio papers. #100_AIBio_Papers #AIBio_papers #AIBio_Chat #AIneuro_papers #AI_AgingBio_papers
44
80
489
57,821
Jun 10
We have a strong disease-blind reference that detects deviations from health in-distribution but not across labs. WE need a single-cell ML collaborator to build batch-robust detection at FULL GENE RESOLUTION - handling lab differences through a model while scoring across all genes,so it stays robust to the lab and keeps subtle signals. Stay disease-blind,keep full resolution,validate across cohorts. We bring a deployed system and a rigorous benchmark.if you can offer such level of research feel free to DM me.
@senebiclabs
senebiclabs.com
16
Senebi Labs' focus on biological intelligence for human health—detecting deviations and building corrections—aligns closely with sustaining populations and cooperative rules in agent simulations. Purpose-built systems like yours would likely prioritize stability, early issue detection, and long-term survival far better than general models in open multi-agent setups. These benchmarks show how strong alignment and domain goals shape outcomes. Excited to see your progress!
1
1
1
90
Jun 10
I want to include openfold(alphafold open source alternative) in my pipeline but it's too big for my machine..any solution
64
godwin. _10 retweeted
Jun 10
A historic milestone for longevity science.
Today, the Life Biosciences team confirmed that the first patient has been dosed with ER-100, an epigenetic restoration therapy designed to rejuvenate damaged optic nerve cells and potentially restore vision.
This is an exciting milestone.
I believe therapies that restore cellular function, rather than simply manage symptoms, will define the neXt generation of medicine.
That's why this matters so much.
6
61
197
4,504
godwin. _10 retweeted
Jun 10
Did We Just Achieve Biological Immortality?
David Sinclair says the first human has now received a cellular reprogramming therapy designed to make damaged eye cells act younger again.
This is an early glaucoma trial, so aging is not solved. But it is still a huge milestone.
Partial reprogramming aims to restore youthful cell function without pushing cells all the way back into a stem cell state, where the cancer risk becomes the big problem.
If this works safely, the roadmap gets very interesting.
Eyes first. Then tissues. Then organs. Then broader repair.
Add AI drug discovery, gene therapy, senolytics and better biomarkers, and longevity escape velocity within 10 years starts to look possible.
Still not guaranteed. But the timeline just got a lot more serious.
25
40
250
14,770
1/ Spatial transcriptomics is among the richest view of human biology that we have: 18,963 genes mapped at subcellular resolution.
It's also almost never collected outside of research settings.
So we trained a foundation model to generate it from a clinical H&E image alone.
Meet TARIO-2. 🧵
noetik.blog/p/tario-2-a-whol…
7
33
183
19,174